Clinical Trials on Safety、Immunogenicity in United States
Total 271 results
-
University of OxfordMRC/UVRI and LSHTM Uganda Research UnitCompleted
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedStem Cell Transplant | Immunogenicity | Gardasil VaccineUnited States
-
Sonoma Biotherapeutics, Inc.Active, not recruiting
-
MicuRxWellcome Trust; Biomedical Advanced Research and Development AuthorityCompleted
-
Recida Therapeutics, Inc.Terminated
-
Provention Bio, Inc.Completed
-
Kaiser PermanenteGarfield Memorial FundCompleted
-
Chris Lascola, MDDuke UniversityWithdrawn
-
Seattle Children's HospitalCompleted
-
Hillier, Sharon, PhDNational Institute of Allergy and Infectious Diseases (NIAID)CompletedPharmacokinetics | SafetyUnited States
-
MedImmune LLCCompletedObservation SafetyUnited States
-
University of Nebraska LincolnNational Institutes of Health (NIH)Completed
-
Equilibre Biopharmaceuticals B.V.CompletedSafety IssuesUnited States
-
VA Office of Research and DevelopmentUniversity of California, San FranciscoNot yet recruiting
-
Montefiore Medical CenterConsano Clinical Research, LLC; Everytown for Gun SafetyCompleted
-
Niconovum USAInflamax Research IncorporatedCompletedSafety IssuesUnited States
-
University of California, San FranciscoCompleted
-
Madrigal Pharmaceuticals, Inc.Completed
-
Northwestern UniversityActive, not recruiting
-
University of MemphisUnilever R&DCompletedTolerance | SafetyUnited States
-
Extend Biosciences Inc.National Institutes of Health (NIH); Pharmaceutical Research Associates; Integrated...Completed
-
Parker UniversityCompleted
-
Viela BioCTI Clinical Trial and Consulting ServicesTerminated
-
Neurop Inc.Completed
-
Ambryx BiotechnologyTexas A&M University; Baylor UniversityCompleted
-
Paion UK Ltd.PRA Health SciencesCompleted
-
Foundation for Orthopaedic Research and EducationSmith & Nephew, Inc.CompletedSafety and PerformanceUnited States
-
Alumis IncCompletedSafety and TolerabilityUnited States
-
Modus Therapeutics ABCompletedPlacebo-controlled Study to Determine the Safety and Tolerability of Subcutaneous Doses of SevuparinSafety and TolerabilityUnited States
-
Phoenix Children's HospitalCompletedChild Passenger SafetyUnited States
-
Kowa Research Institute, Inc.CompletedSafety and TolerabilityUnited States
-
MedImmune LLCCompletedHealthy Subjects | SafetyUnited States, United Kingdom
-
Children's Hospital of PhiladelphiaEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompleted
-
Rinovum Women's Health, Inc.Completed
-
Legend Labz, Inc.RecruitingSafety IssuesUnited States
-
Madrigal Pharmaceuticals, Inc.Completed
-
Phloronol Inc.Worldwide Clinical TrialsCompleted
-
GE Healthcarei3 StatprobeCompleted
-
University of South CarolinaNutrasource Pharmaceutical and Nutraceutical Services, Inc.CompletedHealthy | Safety IssuesUnited States
-
Pennington Biomedical Research CenterLouisiana Clinical and Translational Science CenterCompletedPharmacokinetics | Safety IssuesUnited States
-
Neurodegenerative Disease Research IncRecruitingTolerance | Safety IssuesUnited States
-
Altasciences Company Inc.CompletedPharmacokinetics | Pharmacodynamics | SafetyUnited States
-
Usona InstituteCompletedPharmacokinetics | Tolerability | SafetyUnited States
-
Pennington Biomedical Research CenterNational Institute on Aging (NIA)Completed
-
National Institute of Environmental Health Sciences...Terminated
-
University of Alabama at BirminghamEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedChild Pedestrian SafetyUnited States
-
Yuejia Pharmaceuticals (USA), Inc.Zhejiang Yuejia Pharmaceuticals Co., Ltd.CompletedSafety and TolerabilityUnited States
-
MerLion Pharmaceuticals GmbHCompletedSafety and TolerabilityUnited States
-
Lancaster General HospitalWithdrawn